ES2066278T3 - Derivados del alcoxipirimidina contra la migraña. - Google Patents

Derivados del alcoxipirimidina contra la migraña.

Info

Publication number
ES2066278T3
ES2066278T3 ES91110376T ES91110376T ES2066278T3 ES 2066278 T3 ES2066278 T3 ES 2066278T3 ES 91110376 T ES91110376 T ES 91110376T ES 91110376 T ES91110376 T ES 91110376T ES 2066278 T3 ES2066278 T3 ES 2066278T3
Authority
ES
Spain
Prior art keywords
alcoxipirimidina
derivatives
against migraine
migraine
indolylalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91110376T
Other languages
English (en)
Inventor
David W Smith
Frank D Yocca
Joseph P Yevich
Ronald J Mattson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2066278T3 publication Critical patent/ES2066278T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fats And Perfumes (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

CIERTAS 1-INDOLILALQUIL-4-[4-(5-ALCOXI)-PIRIMIDINIL] PIPERACINAS Y SUS SALES FARMACOLOGICAMENTE ACEPTABLES SON UTILES PARA EL TRATAMIENTO DEL DOLOR DE CABEZA VASCULAR.
ES91110376T 1990-06-29 1991-06-24 Derivados del alcoxipirimidina contra la migraña. Expired - Lifetime ES2066278T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54612290A 1990-06-29 1990-06-29
US68020891A 1991-04-04 1991-04-04
SG15595A SG15595G (en) 1990-06-29 1995-01-30 Antimigraine alkoxypyrimidine derivatives

Publications (1)

Publication Number Publication Date
ES2066278T3 true ES2066278T3 (es) 1995-03-01

Family

ID=27356028

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91110376T Expired - Lifetime ES2066278T3 (es) 1990-06-29 1991-06-24 Derivados del alcoxipirimidina contra la migraña.

Country Status (15)

Country Link
US (1) US5300506A (es)
EP (1) EP0464558B1 (es)
JP (1) JPH04230378A (es)
AT (1) ATE116312T1 (es)
AU (1) AU643038B2 (es)
CA (1) CA2043709C (es)
CY (1) CY1831A (es)
DE (1) DE69106237T2 (es)
DK (1) DK0464558T3 (es)
ES (1) ES2066278T3 (es)
FI (1) FI101224B1 (es)
HK (1) HK51995A (es)
IE (1) IE66687B1 (es)
PT (1) PT98115B (es)
SG (1) SG15595G (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2084531A1 (en) * 1991-12-19 1993-06-20 David W. Smith Antimigraine 4-pyrimidinyl and pyridinyl derivatives of indol-3yl-alkyl piperazines
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
GB9226610D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
CA2130078A1 (en) * 1993-09-16 1995-03-17 Jonas A. Gylys Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
US5550239A (en) * 1994-11-08 1996-08-27 Bristol-Myers Squibb Company Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
AU6386196A (en) * 1995-06-19 1997-01-15 Eli Lilly And Company Process for parallel synthesis of a non-peptide library
WO1997006159A1 (en) * 1995-08-07 1997-02-20 Merck Sharp & Dohme Limited Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
FR2799463B1 (fr) * 1999-10-12 2004-04-16 Adir Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US6800637B2 (en) 2002-09-12 2004-10-05 Wyeth Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines
EP1632491A1 (en) * 2004-08-30 2006-03-08 Laboratorios Del Dr. Esteve, S.A. Substituted indole compounds and their use as 5-HT6 receptor modulators
EP1931648A2 (en) * 2006-08-29 2008-06-18 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 5-phenyl -1 trityl-1h-tetrazole
EP2036888A1 (en) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Naphthyl-substituted sulfonamides
CA2718138A1 (en) * 2008-03-14 2009-09-17 Timo Heinrich Azaindole compounds for treatment of central nervous system disorders
US20090281114A1 (en) * 2008-05-08 2009-11-12 Fabre-Kramer Pharmaceuticals, Inc. Indolylalkyl derivatives of pyrimidinylpiperazine and metabolites thereof for treatment of anxiety, depression, and sexual dysfunction
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (es) * 1959-09-25 1900-01-01
GB1189064A (en) * 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
DE2110534C3 (de) * 1970-03-06 1979-03-08 Sumitomo Chemical Co., Ltd., Osaka (Japan) γ-Piperazinobutyrophenonderivate, Verfahren zu ihrer Herstellung und Arzneipräparate
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8601959D0 (en) * 1986-01-28 1986-03-05 Glaxo Group Ltd Indole derivatives
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines

Also Published As

Publication number Publication date
AU643038B2 (en) 1993-11-04
PT98115B (pt) 1998-12-31
FI101224B (fi) 1998-05-15
ATE116312T1 (de) 1995-01-15
DK0464558T3 (da) 1995-03-13
EP0464558B1 (en) 1994-12-28
IE66687B1 (en) 1996-01-24
FI101224B1 (fi) 1998-05-15
CA2043709A1 (en) 1991-12-30
CA2043709C (en) 2002-01-22
JPH04230378A (ja) 1992-08-19
PT98115A (pt) 1992-03-31
FI913142A0 (fi) 1991-06-27
DE69106237T2 (de) 1995-05-11
DE69106237D1 (de) 1995-02-09
HK51995A (en) 1995-04-13
US5300506A (en) 1994-04-05
EP0464558A1 (en) 1992-01-08
SG15595G (en) 1995-06-16
IE912280A1 (en) 1992-01-01
AU7941691A (en) 1992-01-02
CY1831A (en) 1995-12-01
FI913142A (fi) 1991-12-30

Similar Documents

Publication Publication Date Title
ES2066278T3 (es) Derivados del alcoxipirimidina contra la migraña.
HK1024232A1 (en) Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl)piperazines
FI932032A0 (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
DE69623899D1 (de) Behandlung von Tinnitus mit neuroprotektiven Wirkstoffen
DE60112055D1 (de) Inhibitoren von gamma-secretase
EP0276536A3 (en) Use of buspirone for the improvement of short term memory
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
ATE116316T1 (de) Antipsychotische 4-(1,2- benzisoazolyl)piperidinderivate.
NO890046D0 (no) Disubstituerte pyridiner.
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
ATE119773T1 (de) Thiazolidin-derivate mit antihypertensiver aktivität und deren therapeutische anwendung.
HK1005016A1 (en) Use of buspirone in sleep apneas
NO971261L (no) Kinoksalin-derivater nyttige innen terapi
DE3777665D1 (de) Heptanoyl-glu-asp-ala-amino-saeure-immunstimulanten.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
ZA923747B (en) The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
ES2105986A1 (es) Utilizacion de los derivados de 2-(4-(azolilbutil)(metil)) bencimidazol y analogos, asi como de sus sales, para la preparacion de medicamentos destinados al tratamiento o a la profilaxis del asma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464558

Country of ref document: ES